Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Spring;14(2):651-6.

Evaluation of factors affecting prescribing behaviors, in iran pharmaceutical market by econometric methods

Nima Tahmasebi  1 , Abbas Kebriaeezadeh  2
Affiliations

Evaluation of factors affecting prescribing behaviors, in iran pharmaceutical market by econometric methods

Nima Tahmasebi et al. Iran J Pharm Res. 2015 Spring.

Abstract

Prescribing behavior of physicians affected by many factors. The present study is aimed at discovering the simultaneous effects of the evaluated factors (including: price, promotion and demographic characteristics of physicians) and quantification of these effects. In order to estimate these effects, Fluvoxamine (an antidepressant drug) was selected and the model was figured out by panel data method in econometrics. We found that insurance and advertisement respectively are the most effective on increasing the frequency of prescribing, whilst negative correlation was observed between price and the frequency of prescribing a drug. Also brand type is more sensitive to negative effect of price than to generic. Furthermore, demand for a prescription drug is related with physician demographics (age and sex). According to the results of this study, pharmaceutical companies should pay more attention to the demographic characteristics of physicians (age and sex) and their advertisement and pricing strategies.

Keywords: Advertisement; Characteristics of physicians; Drug sales; Econometrics; Price.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Rajabzadeh A, Mehralian GH, Zarenezhad F. Developing a model for agile Supply: an empirical study from Iranian pharmaceutical supply chain. Iran. J. Pharm. Res. 2013;12:189–201. - PMC - PubMed
    1. Kebriaeezadeh A, Nassiri N, Abdollahiasl A, Nikfar S, Mohamadi N. Trend analysis of the pharmaceutical market in Iran; 1997–2010; policy implications for developing. Daru J. Pharm. Sci. 2013;21:52–60. - PMC - PubMed
    1. Mehralian GH, Rajabzadeh A, Morakabatic M, Vatanpour H. Developing a suitable model for supplier selection based on supply chain risks: an empirical study from iranian pharmaceutical companies. Iran. J. Pharm. Res. 2012;11:209–219. - PMC - PubMed
    1. Cheraghali AM. Current status of biopharmaceuticals in iran’s pharmaceutical Market. GaBI. J. 2013;2:26–29.
    1. Cambridge: National Bureau of Economic Research; Empirical Implications of Physician Authority in PharmaceuticalDecision making. pp. 7–9. working paper 6851 .

LinkOut - more resources